📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: AavantiBio

1.1 - Company Overview

AavantiBio Logo

AavantiBio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of gene transfer and gene editing therapies to treat genetic diseases; a biopharmaceutical company.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to AavantiBio

Alnylam Logo

Alnylam

HQ: United States Website
  • Description: Provider of RNA interference (RNAi) therapeutics, focused on discovery, development and commercialization for rare genetic diseases; pipeline includes investigational genetic medicines and RNAi-based treatments for cardio-metabolic, infectious, central nervous system and ocular diseases; offers products for hereditary ATTR (hATTR) amyloidosis with polyneuropathy and related conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Alnylam company profile →
Regulus Therapeutics Logo

Regulus Therapeutics

HQ: United States Website
  • Description: Provider of microRNA-based therapeutics designed to inhibit dysregulated microRNA targets for genetically based orphan diseases, particularly orphan kidney diseases. Portfolio includes RGLS8429, a next-generation anti-miR-17 in Phase 1b for autosomal dominant polycystic kidney disease (ADPKD), supported by ongoing clinical trials to evaluate efficacy and safety.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Regulus Therapeutics company profile →
DNA Therapeutics Logo

DNA Therapeutics

HQ: France Website
  • Description: Provider of clinical-stage biopharmaceutical development as a privately held company.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DNA Therapeutics company profile →
Skyhawk Therapeutics Logo

Skyhawk Therapeutics

HQ: United States Website
  • Description: Provider of small molecule therapeutics and RNA-targeting platforms that correct RNA expression. Offers SKYSTAR for RNA target assessment and prioritization; SKYLIBRARY of RNA-targeting compounds; SKYSEQ multiplex screening for testing multiple RNA targets; and SKYAI machine-learning tools for advancing RNA splicing modulators. Pipeline includes SKY-0515, a small molecule RNA splicing modifier for Huntington’s disease in clinical trials.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Skyhawk Therapeutics company profile →
Cardior Pharmaceuticals Logo

Cardior Pharmaceuticals

HQ: Germany Website
  • Description: Provider of non-coding RNA-based therapeutics and related tools for heart disease, including CDR132L (Phase 2) to halt and reverse cardiac remodeling after myocardial infarction; clinical trials in heart failure and MI; the CardiorHealth miR-132 PCR kit to measure circulating miR-132; and an H19 gene therapy approach targeting cardiac hypertrophy and heart failure.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cardior Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for AavantiBio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to AavantiBio

2.2 - Growth funds investing in similar companies to AavantiBio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for AavantiBio

4.2 - Public trading comparable groups for AavantiBio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to AavantiBio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About AavantiBio

What does AavantiBio do?

AavantiBio is a provider of gene transfer and gene editing therapies to treat genetic diseases; a biopharmaceutical company.

Who are AavantiBio's competitors?

AavantiBio's competitors and similar companies include Alnylam, Regulus Therapeutics, DNA Therapeutics, Skyhawk Therapeutics, and Cardior Pharmaceuticals.

Where is AavantiBio headquartered?

AavantiBio is headquartered in United States.

How many employees does AavantiBio have?

AavantiBio has 1,000 employees 🔒.

When was AavantiBio founded?

AavantiBio was founded in 2010 🔒.

What sector and industry vertical is AavantiBio in?

AavantiBio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for AavantiBio

Who are the top strategic acquirers in AavantiBio's sector and industry

Top strategic M&A buyers and acquirers in AavantiBio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for AavantiBio?

Top strategic M&A buyers groups and sectors for AavantiBio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in AavantiBio's sector and industry vertical

Which are the top PE firms investing in AavantiBio's sector and industry vertical?

Top PE firms investing in AavantiBio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in AavantiBio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in AavantiBio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in AavantiBio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to AavantiBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in AavantiBio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for AavantiBio?

The key public trading comparables and valuation benchmarks for AavantiBio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for AavantiBio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for AavantiBio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in AavantiBio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for AavantiBio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in AavantiBio's' sector and industry vertical?

Access recent funding rounds and capital raises in AavantiBio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for AavantiBio